Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019
ONSIW
ONSIW was delisted on the 3rd of December, 2018.
6 hedge funds and large institutions have $148K invested in Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 in 2018 Q1 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 0 reducing their positions, and 1 closing their positions.
393% more capital invested
Capital invested by funds: $30K → $148K (+$118K)
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
20% more funds holding
Funds holding: 5 → 6 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
+$1.01K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$223 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MWNA
1
Marshall Wace North America
New York
| $125K | – | – | – |
|
|
CAM
2
Cormorant Asset Management
Boston,
Massachusetts
| $15K | – | – | – |
|
|
ACA
3
Avoro Capital Advisors
New York
| $5K | – | – | – |
|
|
PC
4
PointState Capital
New York
| $2K | – | – | – |
|
|
MIM
5
Monashee Investment Management
Boston,
Massachusetts
| $1K | +$1.01K | +25,000 | New |
|
|
SM
6
Sabby Management
Miami Beach,
Florida
| – | -$3K | -89,644 | Closed |
|
|
7
UBS Group
Zurich,
Switzerland
| – | +$223 | +5,529 | New |
|
ONSIW Hedge Fund Activity: Q1 2018 in Review
6 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 (ONSIW) for Q1 2018, worth a combined $148K — up 393% from $30K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new ONSIW positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Monashee Investment Management, opening a new position worth an estimated $1.01K. The largest seller was Sabby Management, exiting entirely with an estimated $3K sold.
- 6 institutional investors held Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 (ONSIW) as of Q1 2018, up from 5 in Q4 2017.
- Funds reported $148K of Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 stock for Q1 2018, up 393% quarter-over-quarter.
- 2 funds opened new Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 positions in Q1 2018 and 1 closed out, a net change of +1 holder.
- The largest Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 buyer in Q1 2018 was Monashee Investment Management, an estimated $1.01K added.
- The largest Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 seller in Q1 2018 was Sabby Management, an estimated $3K sold.
Based on aggregated 13F filings for Q1 2018.